Reaction

Emergency Care reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,934 reports · 73 co-occurring drugs

As of the last recalculation, Emergency Care appears in 2,934 FAERS reports alongside 73 co-occurring drug terms. The strongest observed disproportionality signal is CANNABIDIOL (PRR 104.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Cannabidiol	308	104.2	105.6
Voxelotor	125	41.2	41.5
Epoprostenol	55	30.4	30.5
Calcium, Magnesium, Potassium, And Sodium Oxybates	29	24.1	24.2
Elexacaftor, Tezacaftor, And Ivacaftor	33	19.0	19.0
Abaloparatide	66	16.3	16.3
Dornase Alfa	42	15.4	15.4
Amikacin	31	13.0	13.0
Riociguat	58	12.9	12.9
Fremanezumab-Vfrm	17	10.6	10.6
Macitentan	99	10.5	10.5
Fluticasone Propionate And Salmeterol	56	9.7	9.7
Ivacaftor	10	9.0	9.0
Bupivacaine	11	8.4	8.4
Lumacaftor And Ivacaftor	10	8.3	8.3
Selexipag	28	7.8	7.8
Tafamidis	12	7.3	7.3
Vigabatrin	14	6.8	6.8
Mepolizumab	44	6.4	6.4
Regorafenib	10	6.1	6.1
Hydroxyurea	18	6.1	6.1
Apalutamide	10	6.1	6.1
Tobramycin	20	5.9	5.9
Tobramycin Solution	10	5.9	5.9
Tobramycin Sulfate	10	5.7	5.7
Rimegepant Sulfate	10	5.6	5.6
Terazosin Hydrochloride	7	5.6	5.6
Fluticasone Propionate And Salmeterol Xinafoate	46	5.5	5.5
Sildenafil	42	5.2	5.2
Niraparib	16	5.1	5.1
Everolimus Tablets	12	5.1	5.1
Carbidopa And Levodopa	32	4.8	4.8
Pancrelipase	26	4.8	4.8
Clobazam	16	4.7	4.7
Fluticasone Furoate And Vilanterol Trifenatate	23	4.6	4.6
Buspirone Hydrochloride	7	4.5	4.5
Sodium Oxybate	40	4.4	4.4
Cenobamate	5	4.3	4.3
Sildenafil Citrate	70	4.0	4.0
Dolutegravir Sodium	5	3.9	3.9
Phenobarbital	8	3.9	3.9
Umeclidinium Bromide And Vilanterol Trifenatate	9	3.8	3.8
Belimumab	17	3.8	3.8
Temozolomide	11	3.7	3.7
Esketamine Hydrochloride	9	3.6	3.6
Abemaciclib	10	3.6	3.6
Paliperidone Palmitate	16	3.5	3.5
Pimavanserin Tartrate	26	3.4	3.4
Testosterone Cypionate	4	3.2	3.2
Abiraterone	6	3.1	3.1
Bosentan	22	3.1	3.1
Tadalafil	43	3.1	3.1
Cariprazine	4	3.1	3.1
Armodafinil	9	3.0	3.0
Eltrombopag Olamine	9	2.8	2.8
Ambrisentan	45	2.6	2.6
Valbenazine	9	2.5	2.5
Treprostinil	44	2.5	2.5
Emtricitabine And Tenofovir Alafenamide	4	2.5	2.5
Ixekizumab	13	2.5	2.5
Alpelisib	3	2.4	2.4
Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate	14	2.4	2.4
Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate	6	2.4	2.4
Naltrexone	9	2.1	2.1
Patiromer	4	2.1	2.1
Budesonide, Glycopyrrolate, And Formoterol Fumarate	3	2.0	2.0
Droxidopa	6	2.0	2.0
Pirfenidone	10	1.7	1.7
Abiraterone Acetate	10	1.7	1.7
Palivizumab	3	1.4	1.4
Dupilumab	75	1.1	1.1
Guselkumab	5	1.0	1.0
Galcanezumab-Gnlm	4	0.9	0.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.